The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease

被引:3
|
作者
Hu, Yingying [1 ,2 ]
Zhou, Fan [3 ,4 ]
Lei, Fang [2 ,5 ]
Lin, Lijin [1 ,2 ]
Huang, Xuewei [6 ]
Sun, Tao [1 ,2 ]
Liu, Weifang [1 ,2 ]
Zhang, Xingyuan [2 ,5 ]
Cai, Jingjing [2 ,6 ]
She, Zhi-Gang [1 ,2 ]
Li, Hongliang [1 ,2 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China
[2] Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China
[3] Yangtze Univ, Huanggang Cent Hosp, Dept Gastroenterol, Huanggang, Peoples R China
[4] Huanggang Inst Translat Med, Huanggang, Peoples R China
[5] Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China
[6] Cent South Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
基金
美国国家科学基金会;
关键词
metabolic dysfunction-associated fatty liver disease; thyroid function parameters; nonlinear relationship; restricted cubic spline analysis; multivariable-adjusted logistic regression models; STIMULATES LEPTIN SECRETION; FREE TRIIODOTHYRONINE; ADIPOSE-TISSUE; HORMONE; RISK; NAFLD; HYPOTHYROIDISM; PATHOGENESIS; THYROTROPIN; PREVALENCE;
D O I
10.3389/fendo.2023.1115354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease (MAFLD) remains controversial. Additionally, little is known about the relationship between thyroid function parameters and MAFLD in the Chinese population. MethodsWe conducted a retrospective cross-sectional study involving 177,540 individuals with thyroid function tests and MAFLD diagnosis from 2010-2018. The association between thyroid function parameters and MAFLD was evaluated on a continuous scale with restricted cubic spline (RCS) models and by the prior-defined centile categories with multivariable-adjusted logistic regression models. Thyroid function parameters included free triiodothyronine (FT3), free tetra-iodothyronine (FT4), and thyroid stimulating hormone (TSH). Additionally, fully adjusted RCS models stratified by sex, age, and location were studied. ResultsIn the RCS models, the risk of MAFLD increased with higher levels of FT3 when FT3 <5.58pmol/L, while the risk of MAFLD decreased with higher levels of FT3 when FT3 >= 5.58pmol/L (P nonlinearity <0.05). While RCS analysis suggested that the FT4 levels had a negative association with MAFLD (P nonlinearity <0.05), indicating an increase in FT4 levels was associated with a decreased risk of MAFLD. RCS analysis suggested an overall positive association between the concentration of TSH and MAFLD risk (P nonlinearity <0.05). The rising slope was sharper when the TSH concentration was less than 1.79uIU/mL, which indicated the association between TSH and MAFLD risk was tightly interrelated within this range. The multivariable logistic regression showed that populations in the 81st-95th centile had the highest risk of MAFLD among all centiles of FT3/TSH, with the 1st-5th centile as the reference category. ConclusionsOur study suggested nonlinear relationships between thyroid function parameters and MAFLD. Thyroid function parameters could be additional modifiable risk factors apart from the proven risk factors to steer new avenues regarding MAFLD prevention and treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes
    Zhang, Xiaodan
    Chen, Yimei
    Ye, Huiyu
    Luo, Zirui
    Li, Jiahong
    Chen, Zhishan
    Zhang, Enting
    Li, Wangen
    ENDOCRINE, 2023, 80 (02) : 366 - 379
  • [2] Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease
    Chen, Yu-ling
    Tian, Shen
    Wu, Juan
    Li, Hao
    Li, Shu
    Xu, Zhou
    Liang, Xin-yu
    Adhikari, Vishnu Prasad
    Xiao, Jun
    Song, Jing-yu
    Ma, Chen-yu
    She, Rui-ling
    Li, Zhao-xing
    Wu, Kai-nan
    Kong, Ling-quan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (07): : E434 - E443
  • [3] Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Thyroid Function in Childhood Obesity: A Vicious Circle?
    Calcaterra, Valeria
    Degrassi, Irene
    Taranto, Silvia
    Porro, Cecilia
    Bianchi, Alice
    L'assainato, Sara
    Silvestro, Giustino Simone
    Quatrale, Antonia
    Zuccotti, Gianvincenzo
    CHILDREN-BASEL, 2024, 11 (02):
  • [4] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Michel, Maurice
    Labenz, Christian
    Armandi, Angelo
    Kaps, Leonard
    Kremer, Wolfgang Maximilian
    Galle, Peter R.
    Grimm, Daniel
    Sprinzl, Martin
    Schattenberg, Joern M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
    Lim, Soo
    Kim, Jin-Wook
    Targher, Giovanni
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021, 32 (07): : 500 - 514
  • [6] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Bhopale, Kamlesh K.
    Srinivasan, Mukund P.
    LIVERS, 2023, 3 (04): : 597 - 617
  • [7] The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
    Wei, Suosu
    Hao, Yanrong
    Dong, Xiaofeng
    Huang, Junzhang
    Huang, Kai
    Xie, Yujie
    Liu, Hongjun
    Wei, Chunyu
    Xu, Jinan
    Huang, Wei
    Dong, Lingguang
    Yang, Jianrong
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [8] Association between metabolic dysfunction-associated fatty liver disease and abdominal aortic aneurysm
    Jia, Yu
    Li, Yizhou
    Yu, Jing
    Jiang, Wenli
    Liu, Yi
    Zeng, Rui
    Wan, Zhi
    Liao, Xiaoyang
    Li, Dongze
    Zhao, Qian
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (04) : 953 - 962
  • [9] Low-Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease
    Zuarth-Vazquez, Julia
    Moreno-Castaneda, Lidia
    Soriano-Marquez, Juan Pablo
    Velazquez-Aleman, Alain
    Ramos-Ostos, Martha Helena
    Uribe, Misael
    Lopez-Mendez, Ivan
    Juarez-Hernandez, Eva
    LIFE-BASEL, 2023, 13 (04):
  • [10] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Fan, Hong
    Li, Lili
    Liu, Zhenqiu
    Zhang, Pengyan
    Wu, Sheng
    Han, Xinyu
    Chen, Xingdong
    Suo, Chen
    Cao, Liou
    Zhang, Tiejun
    BMC GASTROENTEROLOGY, 2023, 23 (01)